Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market To Reach USD 783 Million By 2026 | Reports And Data
November 18, 2019 10:14 ET
|
Reports and Data
New york, Nov. 18, 2019 (GLOBE NEWSWIRE) -- High target disease prevalence, product launches, increasing strategic developments such as partnerships and agreements, favorable research funding...
Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Worth $566.37 Million By 2020 : Radiant Insights,Inc
April 05, 2016 01:32 ET
|
Radiant Insights
San Francisco, April 05, 2016 (GLOBE NEWSWIRE) -- Global ITP therapeutics market is expected to reach USD 566.37 million by 2020. Introduction of new drugs especially pertaining to TPO-RA and...